Non-alcoholic fatty liver disease in cerebrovascular disease: a bystander or a real risk factor?

Hepatol Int. 2022 Feb;16(1):24-26. doi: 10.1007/s12072-021-10273-9. Epub 2022 Jan 27.

Authors

Lung-Yi Mak^{1

2}, James Fung^{3

4}

Affiliations

¹ Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
² State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
³ State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China. jfung@gastro.hk.
⁴ Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Room 305, New Clinical Building, Pokfulam Road 102, Hong Kong, China. jfung@gastro.hk.

PMID: 35088389
DOI: 10.1007/s12072-021-10273-9

No abstract available

Publication types

Editorial

MeSH terms

Cerebrovascular Disorders* / epidemiology
Cerebrovascular Disorders* / etiology
Humans
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / epidemiology
Risk Factors